Abstract:Li-Hua Deng, 1, 2 Hai Jiang, 1 Fu-Lin Lu, 1 Han-Wei Wang, 1 Yu Pu, 1 Chang-Qiang Wu, 1 Hong-Jie Tang, 3 Ye Xu, 4 Tian-Wu Chen, 1 Jiang Zhu, 1 Cheng-Yi Shen, 1 Xiao-Ming Zhang 1 1 Medical Imaging Key Laboratory of Sichuan Province and School of Medical Imaging, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, People's Republic of China; 2 Department of Radiology, First People's Hospital of Neijiang, Neijiang 641000, People's Republic of China; 3 Department of Radiology, Nanchong Hospital of Traditional Chinese Medicine, Nanchong 637000, People's Republic of China; 4 Department of Radiology, Children's Hospital of Chongqing Medical University, Chongqing 401122, People's Republic of China Correspondence: Chang-Qiang Wu; Xiaoming Zhang Sichuan Key Laboratory of Medical Imaging and School of Medical Imaging, Affiliated Hospital of North Sichuan Medical College, 234th Fujiang Road, Nanchong 637000, People's Republic of China Tel +86-13990723836 Email wucq1984@163.com; zhangxm@nsmc.edu.cn Objective: PEGylated superparamagnetic iron oxide (SPIO) is the most promising alternatives to gadolinium-based contrast agents (GBCAs) in MRI. This paper is to explore the imaging effects of PEGylated SPIO, which is influenced by particle sizes and surface polyethylene glycol (PEG) coating, using as MRI contrast agents at different magnetic field intensities. Methods: Firstly, nine PEGylated monocrystalline SPIO nanoparticles with different nanocrystal sizes and different molecular weights PEG coating were prepared, and then physical and biological properties were analyzed. Finally, MRI imaging in vivo was performed to observe the imaging performance. Results: Nine PEGylated monocrystalline SPIO nanoparticles have good relaxivities, serum stability, and biosecurity. At the same time, they show different imaging characteristics at different magnetic field intensities. Eight-nanometer SPIO@PEG5k is an effective T 2 contrast agent at 3.0 T ( r 2 / r 1 = 14.0), is an ideal T 1 - T 2 dual-mode contrast agent at 1.5 T ( r 2 / r 1 = 6.52), and is also an effective T 1 contrast agent at 0.5 T ( r 2 / r 1 = 2.49), while 4-nm SPIO@PEG5k is a T 1 - T 2 dual-mode contrast agent at 3.0 T ( r 2 / r 1 = 5.24), and is a useful T 1 contrast agent at 0.5 T ( r 2 / r 1 = 1.74) and 1.5 T ( r 2 / r 1 = 2.85). MRI studies in vivo at 3.0 T further confirm that 4-nm SPIO@PEG5k displays excellent T 1 - T 2 dual-mode contrast enhancement, whereas 8-nm SPIO@PEG5k only displays T 2 contrast enhancement. Conclusion: PEGylated SPIOs with different nanocrystal sizes and PEG coating can be used as T 1 , T 2 , or T 1 - T 2 dual-mode contrast agents to meet the clinical demands of MRI at specific magnetic fields. Keywords: magnetic resonance imaging, contrast agents, superparamagnetic iron oxide, polyethylene glycol

Synthesis and Characterization of PVP-coated Large Core Iron Oxide Nanoparticles As an MRI Contrast Agent.

A Novel One-Pot Synthesis of PVP-Coated Iron Oxide Nanoparticles as Biocompatible Contrast Agents for Enhanced T2-Weighted MRI

Effects of Nanoparticle Size on Cellular Uptake and Liver MRI with Polyvinylpyrrolidone-Coated Iron Oxide Nanoparticles

Synthesis of PVP Coated Superparamagnetic Iron Oxide Nanoparticles with a High Saturation Magnetization

Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent.

Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.

Delayed hepatic uptake of multi-phosphonic acid poly(ethylene glycol) coated iron oxide measured by real-time Magnetic Resonance Imaging

The Effect of Surface Coating of Iron Oxide Nanoparticles on Magnetic Resonance Imaging Relaxivity

Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast<i>T</i><sub>1</sub>- and<i>T</i><sub>2</sub>-weighted magnetic resonance imaging

Characterization and in Vitro Cellular Uptake of PEG Coated Iron Oxide Nanoparticles As MRI Contrast Agent.

Preparation of Mn2+@PolyDOPA-b-polysarcosine Micelle As MRI Contrast Agent with High Longitudinal Relaxivity

Synthesis of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles with High Relaxivity for T1/T2 Dual-Contrast Magnetic Resonance Imaging

Size and PEG Length-Controlled PEGylated Monocrystalline Superparamagnetic Iron Oxide Nanocomposite for MRI Contrast Agent

Fe3O4 Nanoparticles Functionalized with Polymer Ligand for T-1-Weighted MRI in Vitro and in Vivo

Synthesize and Characterization of Multifunctional Silica Coated Magnetic Nanoparticles Using Polyvinylpyrrolidone (PVP) as a Mediator

Polyol Synthesis of Superparamagnetic Fe_3O_4 Nanoparticles for Magnetic Resonance Imaging

Synthesis of well-dispersed aqueous-phase magnetite nanoparticles and their metabolism as an MRI contrast agent for the reticuloendothelial system

Precise Study on Size-Dependent Properties of Magnetic Iron Oxide Nanoparticles for in Vivo Magnetic Resonance Imaging

A T1/T2 dual functional iron oxide MRI contrast agent with super stability and low hypersensitivity benefited by ultrahigh carboxyl group density

2, 3-Dimercaptosuccinic Acid-Modified Iron Oxide Clusters for Magnetic Resonance Imaging

Metallic Iron Nanoparticles for MRI Contrast Enhancement and Local Hyperthermia.